lactose has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Kawabata, Y; Kojo, Y; Mizumoto, T; Ogawa, K; Onoue, S; Sato, H; Wada, K; Yamada, S | 1 |
| Kasuya, Y; Kumon, M; Kusai, A; Suzuki, M; Terada, K; Yabe, Y; Yonemochi, E | 1 |
2 other study(ies) available for lactose and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Drug Carriers; Emulsifying Agents; Emulsions; Glycerides; Lactose; Male; Particle Size; Povidone; Powders; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
Applicability of DPI formulations for novel neurokinin receptor antagonist.
Topics: Administration, Inhalation; Animals; Area Under Curve; Asthma; Chemistry, Pharmaceutical; Cyclic S-Oxides; Excipients; Half-Life; Lactose; Male; Morpholines; Nebulizers and Vaporizers; Powders; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-2 | 2008 |